Search For "biopharma"
Biocon Biologics gets Rs 555 crore capital injection from ADQ
Updated : 5 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 7 (ANI): Abu Dhabi-based ADQ will invest Rs 555 crore for 1.8 per cent minority stake in Biocon Biologics, valuing it at a post money valuation of 4.17 billion dollars (about Rs 30,482 crore).
Read More
Argentina authorizes use of AstraZeneca vaccine against Covid-19
Updated : 5 years, 2 months ago IST
Buenos Aires [Argentina], December 31 (ANI/Xinhua): Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) on Wednesday approved the use of vaccine from AstraZeneca, a multinational pharmaceutical and biopharmaceutical company, against Covid-19 in the country.
Read More
Bharat Biotech, Ocugen to co-develop Covaxin for United States market
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 22 (ANI): Hyderabad-based Bharat Biotech and US-based biopharmaceutical firm Ocugen Inc on Tuesday announced that they have signed a binding letter of intent (LOI) to co-develop the Indian firm's COVID-19 vaccine candidate--Covaxin-- for the United Sta
Read More
Japan's AnGes begins Phase 2 clinical trials of DNA vaccine against COVID-
Updated : 5 years, 3 months ago IST
Tokyo [Japan], December 8 (ANI/Sputnik): Japan's AnGes biopharmaceutical company said on Tuesday that it had started phase 2 clinical trials of its DNA vaccine against the coronavirus.
Read More
Indonesia receives over 1 million Chinese Covid-19 vaccine doses
Updated : 5 years, 3 months ago IST
Jakarta [Indonesia], December 7 (ANI): Indonesia has received 1.2 million doses of a Covid-19 vaccine made by China's biopharmaceutical company Sinovac Biotech.
Read More
Pfizer, BioNTech submit application to register COVID-19 vaccine in EU
Updated : 5 years, 3 months ago IST
Berlin [Germany], December 1 (ANI/Sputnik): German BioNTech biopharmaceutical company and its US partner Pfizer have submitted a formal application to register their vaccine against coronavirus in the European Union which, if approved, will allow EU nations to start vaccinating their populat
Read More
PM Modi appreciates scientists' efforts to come out with vaccine solution
Updated : 5 years, 3 months ago IST
New Delhi [India], November 30 (ANI): Prime Minister Narendra Modi on Monday appreciated the efforts by scientists in Gennova Biopharmaceuticals Ltd, Biological E Ltd and Dr. Reddys Laboratories Ltd to come out with a vaccine solution to tackle COVID-19.
Read More
AstraZeneca's signs MoU with Indian Diabetes Research Society (RSSDI) to e
Updated : 5 years, 3 months ago IST
Bangalore (Karnataka) [India], November 26 (ANI/PRNewswire): AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today signed a memorandum of understanding with the Research Society for Study of Diabetes in India (RSSDI).
Read More
BioNTech says no infomation on vaccination start in Germany
Updated : 5 years, 4 months ago IST
Berlin [Germany], November 14 (ANI/Sputnik): German BioNTech biopharmaceutical company that had teamed up with US Pfizer for the development of a vaccine against Covid-19, told Sputnik on Friday that it had not yet received the information as to when vaccination will start in Germany
Read More
Bacterial outbreak in China infects thousands of people after factory leak
Updated : 5 years, 5 months ago IST
Beijing [China], September 18 (ANI): Several thousand people in north-east China have tested positive for a bacterial disease in an outbreak caused by a leak at a biopharmaceutical company last year, authorities said on Tuesday.
Read More
AstraZeneca says COVID-19 vaccine trial paused due to unexplained illness
Updated : 5 years, 6 months ago IST
London [UK], September 9 (ANI): UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom.
Read More
Tata Capital to pick minority stake in Biocon Biologics for Rs 225 cr
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 31 (ANI): Private equity major Tata Capital Growth Fund will pick up 0.85 per cent stake in the biologics arm of biopharmaceutical major Biocon for Rs 225 crore.
Read More